SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing significant volatility as the community remains divided between long-term investors tracking institutional accumulation and short-term traders reacting to persistent, algo-driven intraday price fluctuations. Investors are closely monitoring key support levels and the company's progress in expanding its fintech ecosystem as they await upcoming earnings reports.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is trending due to the sale of its experimental complement inhibitor to Akebia Therapeutics for up to several hundred million dollars, a move that is expected to significantly extend the company's cash runway. While some traders view the deal as a major validation of the pipeline and an attractive acquisition target, others are debating whether the market has already priced in the news or if potential dilution and short-interest dynamics will drive further volatility.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility as investors weigh the impact of an upcoming 20-for-1 stock split against aggressive rebalancing moves by the South Korean National Pension Service. The community remains focused on the potential for a massive rally driven by the imminent U.S. listing of SK Hynix, even as leverage-induced selling and broader macro uncertainty fuel intense day-trading debates.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is trending as investors digest blockbuster monthly revenue growth that highlights sustained, AI-driven demand for advanced chip manufacturing. Community discussion remains focused on the company's resilient fundamentals and price-hike potential despite broader market jitters over geopolitical risks.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending as investors react to a significant upward revision in Q2 revenue guidance, which sits well above market expectations and signals strong momentum across its AI infrastructure and contract pipeline. The community is heavily focused on the stock's high short interest, with many anticipating a potential short squeeze as they argue the company's fundamental shift toward contracted revenue and institutional-grade financing makes the current short position increasingly unsustainable.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is capturing significant market attention following its major ADR listing in the U.S., with investors closely monitoring its HBM market dominance as a key proxy for the broader AI infrastructure and memory cycle. While the community is debating potential entry points, much of the discourse centers on whether the stock will trade at a persistent premium compared to its domestic listing or if it will face immediate volatility similar to other high-profile tech IPOs.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is facing heightened scrutiny as investors demand transparency regarding production capabilities and revenue realization, while the stock continues to be heavily influenced by broad defense sector sentiment and speculation surrounding potential government investment. Community sentiment remains deeply polarized between long-term bulls betting on military drone integration and skeptical traders reacting to executive silence, dilution concerns, and delayed contract confirmation.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors favor large-cap healthcare stability amidst broader market rotations, fueled by strong demand for its GLP-1 obesity treatments and a robust, diversified pipeline of future growth assets. Community discussion is heavily focused on the stock's long-term compounding potential, institutional accumulation, and speculation regarding its strategic moves to maintain market dominance.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is drawing significant investor focus as the community debates the likelihood of a strategic buyout following recent clinical data readouts and institutional accumulation. While the stock continues to face competitive pressures in the multiple myeloma space, discussion remains heavily centered on whether current price levels represent an attractive entry for long-term holders or a potential acquisition play by major pharmaceutical partners.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is currently in the spotlight following news of a $100 million investment from Joshua Kushners Thrive Capital, which is fueling investor optimism regarding the firm's AI-driven e-commerce strategy. The community is actively debating the stock's long-term potential, balancing enthusiasm over the institutional backing and a $3 billion buyback plan against ongoing frustrations with recent price volatility and broader sector pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. engages in the research and development, manufacture, and commercialization of novel drugs. It offers proprietary technology platforms focusing on the treatment of breast cancer, non-small cell lung cancer, gastrointestinal cancers, and colorectal cancer, as well as non-oncology diseases. The company was founded by Ge Xin Liu on November 22, 2016 and is headquartered in Chengdu, China.

Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. - Ordinary Shares - Class H

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

SKBHFSichuan Kelun-Biotech Biopharmaceutical Co. Ltd. - Ordinary Shares - Class H

Latest SKBHF News